A systematic review of the effectiveness of employer‐led interventions for drug misuse
Abstract Aims: Employers in the United States incur substantial costs associated with substance use disorders. Our goal was to examine…
Abstract Aims: Employers in the United States incur substantial costs associated with substance use disorders. Our goal was to examine…
Abstract The worldwide prevalence of neurological and neurodegenerative disorders, such as depression or Alzheimer’s disease, has spread extensively throughout the…
Abstract The endocannabinoid system (ECS) acts as a negative feedback mechanism to suppress synaptic transmission and plays a major role…
Abstract Background: Placebo and nocebo effects embody psychoneurobiological phenomena where behavioural, neurophysiological, perceptive and cognitive changes occur during the therapeutic…
Abstract Parkinson’s Disease (PD) is currently the most rapid growing neurodegenerative disease and over the past generation, its global burden…
Abstract Background: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine…
Abstract Mesenchymal stem cells (MSCs) are capable of differentiating into a limited number of diverse cells and secrete regenerative factors…
Abstract Since August 2019, the pulmonary disease termed e‐cigarette or vaping product‐use associated lung injury (EVALI), has resulted in 2758…
Abstract Small inhaled particles, which are entrapped by the mucous layer that is maintained by mucous secretion via mucin exocytosis…
Abstract Cannabidiolic acid (CBDA) is the main phytocannabinoid in fiber and seed-oil hemp (Cannabis sativa L.) plants, but its potential…